Results 111 to 120 of about 61,203 (243)

Silicosarcoidosis: Histologic and Clinical Features of an Occupational Granulomatous Disease

American Journal of Industrial Medicine, Volume 68, Issue 6, Page 491-507, June 2025.
ABSTRACT Sarcoidosis is a multisystem inflammatory disease of unknown etiology. Growing evidence indicates that occupational exposure to respirable crystalline silica (RCS) is associated with an increased incidence of sarcoidosis. Yet a diagnosis of sarcoidosis rarely prompts investigation to identify preventable exposures.
Jeremy T. Hua, Carlyne D. Cool, Einat Fireman Klein, Yochai Adir, Lukas J. Lee, Lauren M. Zell‐Baran, Robert A. Cohen, Richard C. Kraus, E. Brigitte Gottschall, Silpa D. Krefft, Charles Van Hook, Cecile S. Rose   +11 more
wiley   +1 more source

Desmosine: The Rationale for Its Use as a Biomarker of Therapeutic Efficacy in the Treatment of Pulmonary Emphysema. [PDF]

Diagnostics (Basel)
Cantor J.
europepmc   +1 more source

Ninjin'yoeito ameliorated PPE-induced pulmonary emphysema and anxiety/depressive-like behavior in aged C57BL/6J mice. [PDF]

Front Pharmacol, 2022
Shimoyama T, Kaneda M, Yoshida S, Michihara S, Fujita N, Han LK, Takahashi R.   +6 more
europepmc   +1 more source

Observations on the Pulmonary Vasculature in a Case of Centrilobular Emphysema with Hemosiderosis [PDF]

, 1963
Donald Heath, Richard Norris, PAUL H. DAVISON   +2 more
openalex   +1 more source

Subchronic Inhalation of TiO2 Nanoparticles Leads to Deposition in the Lung and Alterations in Erythrocyte Morphology in Mice

Journal of Applied Toxicology, Volume 45, Issue 6, Page 1004-1018, June 2025.
ABSTRACT TiO2 nanoparticles (NPs) are extensively used in various applications, highlighting the importance of ongoing research into their effects. This work belongs among rare whole‐body inhalation studies investigating the effects of TiO2 NPs on mice.
Pavel Kulich, Soňa Marvanová, Radim Skoupý, Miša Škorič, Jan Vysloužil, Omar Šerý, Pavel Mikuška, Lukáš Alexa, Pavel Coufalík, Kamil Křůmal, Pavel Moravec, Zbyněk Večeřa, Miroslav Machala   +12 more
wiley   +1 more source

Elastin Peptides as a Potential Disease Vector in the Pathogenesis of Pulmonary Emphysema: An Investigation of This Hypothesis. [PDF]

Life (Basel)
Cantor J.
europepmc   +1 more source

Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical Trial. [PDF]

Am J Respir Crit Care Med, 2022
Wise RA, Holbrook JT, Brown RH, Criner GJ, Dransfield MT, He J, Henderson RJ, Kaminsky DA, Kaner RJ, Lazarus SC, Make BJ, McCormack MC, Neptune ER, Que LG.   +13 more
europepmc   +1 more source

Thoracic Cancer Exercise Services in Australia: A Point‐Prevalence Survey

Asia-Pacific Journal of Clinical Oncology, Volume 21, Issue 3, Page 328-337, June 2025.
Our Australian prospective, observational, multicenter, and point‐prevalence study found that only 67% of surveyed exercise services accepted lung cancer referrals, with just 38% of these programs providing exercise services to lung cancer patients during the study period, highlighting a gap in the integration of exercise pre‐ and rehabilitation into ...
Amy Bowman, Linda Denehy, Lara Edbrooke
wiley   +1 more source

The Role of the Extracellular Matrix in the Pathogenesis and Treatment of Pulmonary Emphysema. [PDF]

Int J Mol Sci
Cantor J.
europepmc   +1 more source

Quantitative determination of pulmonary emphysema in follow-up LD-CTs of patients with COVID-19 infection. [PDF]

PLoS One, 2022
Celik E, Nelles C, Kottlors J, Fervers P, Goertz L, Pinto Dos Santos D, Achenbach T, Maintz D, Persigehl T.   +8 more
europepmc   +1 more source